Hospital Dvt Prevention
Program

No One Handles More Dvt Patients Than Us

More Americans die from DVT than
breast cancer, AIDS and traffic
fatalities combined.

Patients are at the highest risk
5-10 days post surgery

VTE is a leading cause of
preventable hospital deaths in
United States

The Problem

finan-1

Financial impact

Financial impact rising costs for patient readmittance for DVT or associated wound care from device usage is growing.

insurance

Patient safety

Patient safety adverse drug events, bleeding risks of anti-coagulants can be mitigated by mechanical prophylaxis as stated by the Joint Commission.

patient

Patient Care

Patient are at the highest risk 5-10 days post surgery for DVT. Patient compliance at home is the largest gap in all healthcare. Providing a solution for in home use is the future of post surgery care.

The Solution

We are the #1 Standard of Care for DVT Prevention, providing hospitals the most efficient DVT program nationwide by decreasing your workload, increasing patient outcomes and providing the most compliant program for your hospital.

Financial Impact With Circul8

Earlier Discharge Time

With a portable sequential device the hospitals can now discharge their patients faster. The average in patient stay costs a hospital $2500 per day and up to $150 per hour.

Decreased Readmision

Studies show that when a portable sequential device is used at the home setting the hospitals will decrease their readmission rates for blood clots.

Tubeless Device

Tubeless and single patient devices will reduce the hospital acquired condition rates by decreasing fall risk and infection from contaminated pumps and prevent a patient from tripping over the tubes.

Infection Control

Hospital grade units that weigh up to 7 lbs. require SPD / infection control to wipe down the units with an alcohol wipe and usually clean bag the unit between patients.

Single Patient Use

Materials managers spend 25% of their time tracking pumps, managing reprocessing bins, replacing tubes, and sending the device for repairs. Circul8 is single patient use and travels home with the patient.

No Hidden Cost and Fees

Hospitals typically spend $15-$65 per patient on new cuffs. Current ASP for a hospital and Circul8 will be negotiated. However, hospital will not have hidden costs of $50 for lost tubing, fines for lost pumps, Bio Med repair, labor costs, and manufacturer service costs.

Patient Safety with Circul8

Improve Patient Outcomes

  • Reduce risk of DVT with at home sequential compression device
  • Lower risk/side effects compared to anticoagulants or pharmacologic options
  • Decrease risk of falls in and out of the hospital by eliminating tubes
  • Earlier discharges
  • Reduce risk of wounds by eliminating tubing

Improve Patient Outcomes

  • Provide comfort and relief through compression
  • Improve convenience with tubeless and battery operated design
  • Improve patient scores and feedback with cutting edge technology

Fall Risk And Wound Management

$30,000

Cost to treat a fall

$20,900 – $151,700

Cost to treat a wound

$140,701

Cost to treat a bleeding
complication

Custom Patient Education Portal

Custom Patient Portal for increased patient compliance and increased outcomes.

  • Product Instructions
  • Product Videos
  • Patient Tutorials
  • Frequently Asked Questions
  • Automated Patient Follow Up System
  • Pre-Charged Units
  • Direct Ship Inventory Management

Circul8

The Circul8 is intended to be an easy to use portable system, prescribed by a physician, for use in the home or clinical setting to help prevent the onset of DVT in patients by stimulating blood flow in the extremities (stimulating muscle contractions). This device can be used to:

  • Aid in the prevention of DVT
  • Enhance blood circulation
  • Diminish post-operative pain and swelling
  • Reducing wound healing time

Case Studies

The Journal of Arthroplasty

The DVT rate for the post-discharge protocol of Aspirin and Portable Mechanical Compression therapy group was 0%…

Learn More →

CHEST Guidelines

In patients undergoing total hip arthroplasty (THA) or total knee arthroplasty (TKA), we recommend use of one of the following…

Learn More →

AAOS Guidelines

We suggest the use of pharmacologic agents and/or mechanical compressive devices for the prevention of venous….

Learn More →

Trusted Partners

Join More Than 300 Healthcare Centers And Providers Who Trust Precision Medical Products

Gold Standard

Circul8 Should Be Considered As The Gold Standard For Any Hospital

Financial Impact

Circul8 will speed up discharge, mitigate the risk for a readmission DVT, eliminate large service contracts, reduce labor costs, and decrease the fall risk at the facility.

Patient Safety

Circul8 will improve clinical outcomes by decreasing blood clots and bleeding associated with pharmacalogic options.

Patient Care

Improve patient scores and feedback with cutting edge technology and one of a kind patient education.

Clinical Support

Sequential compression devices have been studied for over 26 years. Recent studies show compresssion therapy with aspirin after a total joint resulted in a blood clot rate of 0%. Board guidelines also recognize the use of this device at the home setting.

Ready to Get Started?

We want to hear from you. Reach out to us with any questions or request for more information.